0 XP   0   0   0

Greenrose Acquisition Corp
Buy, Hold or Sell?

Should you buy, hold or sell Greenrose Acquisition Corp?

I guess you are interested in Greenrose Acquisition Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Greenrose Acquisition Corp

Let's start. I'm going to help you getting a better view of Greenrose Acquisition Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Greenrose Acquisition Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Greenrose Acquisition Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Greenrose Acquisition Corp. The closing price on 2023-02-03 was $0.48 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Greenrose Acquisition Corp Daily Candlestick Chart
Greenrose Acquisition Corp Daily Candlestick Chart
Summary









1. Valuation of Greenrose Acquisition Corp




Current price per share

$0.48

2. Growth of Greenrose Acquisition Corp




Is Greenrose Acquisition Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$14.5m$169.3m-$120.7m-248.4%

How much money is Greenrose Acquisition Corp making?

Current yearPrevious yearGrowGrow %
Making money$6.3m-$871.1k$7.1m113.8%
Net Profit Margin-187.4%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Greenrose Acquisition Corp




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#550 / 705

Most Revenue
#548 / 705

Most Profit
#316 / 705

Most Efficient
#589 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Greenrose Acquisition Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Greenrose Acquisition Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -459.1% means that $-4.59 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Greenrose Acquisition Corp:

  • The MRQ is -459.1%. The company is making a huge loss. -2
  • The TTM is -187.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-459.1%TTM-187.4%-271.7%
TTM-187.4%YOY--187.4%
TTM-187.4%5Y-57.7%-129.7%
5Y-57.7%10Y-57.7%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-459.1%0.4%-459.5%
TTM-187.4%0.3%-187.7%
YOY-0.2%-0.2%
5Y-57.7%-0.7%-57.0%
10Y-57.7%-0.1%-57.6%
1.1.2. Return on Assets

Shows how efficient Greenrose Acquisition Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -20.5% Return on Assets means that Greenrose Acquisition Corp generated $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Greenrose Acquisition Corp:

  • The MRQ is -20.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-20.5%TTM1.1%-21.6%
TTM1.1%YOY-0.5%+1.6%
TTM1.1%5Y0.1%+1.0%
5Y0.1%10Y0.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.5%0.1%-20.6%
TTM1.1%0.1%+1.0%
YOY-0.5%-0.1%-0.4%
5Y0.1%-0.2%+0.3%
10Y0.1%0.1%0.0%
1.1.3. Return on Equity

Shows how efficient Greenrose Acquisition Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -248.0% Return on Equity means Greenrose Acquisition Corp generated $-2.48 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Greenrose Acquisition Corp:

  • The MRQ is -248.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -41.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-248.0%TTM-41.9%-206.0%
TTM-41.9%YOY-13.5%-28.4%
TTM-41.9%5Y-18.3%-23.6%
5Y-18.3%10Y-18.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-248.0%0.6%-248.6%
TTM-41.9%0.4%-42.3%
YOY-13.5%0.4%-13.9%
5Y-18.3%-0.3%-18.0%
10Y-18.3%0.1%-18.4%

1.2. Operating Efficiency of Greenrose Acquisition Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Greenrose Acquisition Corp is operating .

  • Measures how much profit Greenrose Acquisition Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -61.8% means the company generated $-0.62  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Greenrose Acquisition Corp:

  • The MRQ is -61.8%. The company is operating very inefficient. -2
  • The TTM is -36.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-61.8%TTM-36.7%-25.1%
TTM-36.7%YOY--36.7%
TTM-36.7%5Y-11.3%-25.4%
5Y-11.3%10Y-11.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.8%2.5%-64.3%
TTM-36.7%1.6%-38.3%
YOY-2.7%-2.7%
5Y-11.3%1.8%-13.1%
10Y-11.3%0.8%-12.1%
1.2.2. Operating Ratio

Measures how efficient Greenrose Acquisition Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 2.43 means that the operating costs are $2.43 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Greenrose Acquisition Corp:

  • The MRQ is 2.433. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.811. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.433TTM1.811+0.622
TTM1.811YOY-+1.811
TTM1.8115Y0.557+1.254
5Y0.55710Y0.5570.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4331.473+0.960
TTM1.8111.456+0.355
YOY-1.398-1.398
5Y0.5571.374-0.817
10Y0.5571.191-0.634

1.3. Liquidity of Greenrose Acquisition Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Greenrose Acquisition Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.10 means the company has $0.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Greenrose Acquisition Corp:

  • The MRQ is 0.102. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.154. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.154-0.052
TTM0.154YOY0.737-0.583
TTM0.1545Y1.260-1.105
5Y1.26010Y1.2600.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1021.880-1.778
TTM0.1541.901-1.747
YOY0.7372.112-1.375
5Y1.2602.182-0.922
10Y1.2601.891-0.631
1.3.2. Quick Ratio

Measures if Greenrose Acquisition Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Greenrose Acquisition Corp:

  • The MRQ is 0.013. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.022. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.013TTM0.022-0.009
TTM0.022YOY0.643-0.622
TTM0.0225Y0.221-0.199
5Y0.22110Y0.2210.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0130.733-0.720
TTM0.0220.796-0.774
YOY0.6430.808-0.165
5Y0.2210.834-0.613
10Y0.2210.821-0.600

1.4. Solvency of Greenrose Acquisition Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Greenrose Acquisition Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Greenrose Acquisition Corp to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.92 means that Greenrose Acquisition Corp assets are financed with 91.7% credit (debt) and the remaining percentage (100% - 91.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Greenrose Acquisition Corp:

  • The MRQ is 0.917. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.781. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.917TTM0.781+0.136
TTM0.781YOY0.027+0.754
TTM0.7815Y0.391+0.390
5Y0.39110Y0.3910.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9170.437+0.480
TTM0.7810.424+0.357
YOY0.0270.398-0.371
5Y0.3910.398-0.007
10Y0.3910.401-0.010
1.4.2. Debt to Equity Ratio

Measures if Greenrose Acquisition Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 1,109.4% means that company has $11.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Greenrose Acquisition Corp:

  • The MRQ is 11.094. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.883. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ11.094TTM4.883+6.211
TTM4.883YOY0.747+4.137
TTM4.8835Y4.347+0.536
5Y4.34710Y4.3470.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0940.652+10.442
TTM4.8830.675+4.208
YOY0.7470.623+0.124
5Y4.3470.684+3.663
10Y4.3470.697+3.650

2. Market Valuation of Greenrose Acquisition Corp

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Greenrose Acquisition Corp generates.

  • Above 15 is considered overpriced but always compare Greenrose Acquisition Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -0.56 means the investor is paying $-0.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Greenrose Acquisition Corp:

  • The EOD is -0.236. Company is losing money. -2
  • The MRQ is -0.559. Company is losing money. -2
  • The TTM is -2.253. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.236MRQ-0.559+0.324
MRQ-0.559TTM-2.253+1.693
TTM-2.253YOY-166.028+163.775
TTM-2.2535Y-190.842+188.589
5Y-190.84210Y-190.8420.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.236-0.124-0.112
MRQ-0.559-0.437-0.122
TTM-2.253-0.102-2.151
YOY-166.02815.340-181.368
5Y-190.8427.916-198.758
10Y-190.8427.700-198.542
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Greenrose Acquisition Corp.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Greenrose Acquisition Corp:

  • The MRQ is 0.376. Very good. +2
  • The TTM is 6.372. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ0.376TTM6.372-5.996
TTM6.372YOY-187.061+193.433
TTM6.3725Y-694.082+700.455
5Y-694.08210Y-694.0820.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3760.012+0.364
TTM6.3720.010+6.362
YOY-187.0610.004-187.065
5Y-694.0820.010-694.092
10Y-694.0820.021-694.103

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Greenrose Acquisition Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 1.39 means the investor is paying $1.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Greenrose Acquisition Corp:

  • The EOD is 0.584. Very good. +2
  • The MRQ is 1.387. Good. +1
  • The TTM is 1.066. Good. +1
Trends
Current periodCompared to+/- 
EOD0.584MRQ1.387-0.803
MRQ1.387TTM1.066+0.321
TTM1.066YOY1.111-0.046
TTM1.0665Y0.860+0.206
5Y0.86010Y0.8600.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.5841.415-0.831
MRQ1.3871.586-0.199
TTM1.0662.019-0.953
YOY1.1112.230-1.119
5Y0.8601.895-1.035
10Y0.8601.505-0.645
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Greenrose Acquisition Corp.

3.1. Institutions holding Greenrose Acquisition Corp

Institutions are holding 15.152% of the shares of Greenrose Acquisition Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-03-31Karpus Management Inc10.93990.72082395025-596590-19.9421
2021-03-31Hudson Bay Capital Management LP4.62480.12431012485-2057765-67.0227
2021-03-31Anson Funds Management LP4.51841.17449891969891960
2021-03-31Goldman Sachs Group Inc2.87860.001663019028019080.0543
2021-03-31Periscope Capital Inc.2.69540.2319590100369100167.0136
2021-03-31Omni Partners LLP2.5240.2712552558353867178.0992
2021-03-31Castle Creek Arbitrage, LLC2.35640.299515865158653.173
2021-03-31Citadel Advisors Llc2.10880.0011461665-538344-53.8339
2021-03-31Mizuho Securities USA Inc1.87560.3898410611-774389-65.3493
2021-03-31Deutsche Bank AG1.82710.0022400000-197304-33.0324
2021-03-31BOOTHBAY FUND MANAGEMENT, LLC1.75010.142938314400
2021-03-31Tenor Capital Management Co Lp1.66920.0938365419-34581-8.6453
2021-03-31Test Hedge Fund Mgmt1.5280.1253334516178601114.5502
2021-03-31Weiss Asset Management LP1.48010.08713240203175414901.0804
2021-03-31BlueCrest Capital Management Ltd.1.14190.04062500002500000
2020-12-31LMR Partners LLP0.91360.0315200000-299800-59.984
2021-03-31RiverNorth Capital Management, LLC0.90210.11819748400
2021-03-31Vivaldi Asset Management, LLC0.70260.29961538271538270
2021-03-31Athos Capital Ltd0.64790.23591418471418470
2021-03-31Smith Moore & Co0.57860.2042126660103775453.463
Total 47.66314.595210434612-1344964-12.9%

3.2. Funds holding Greenrose Acquisition Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-01-31RiverNorth Opportunities0.33860.45537412800
2020-12-31Picton Mahoney Fortified Arbtrg Pl Alt F0.2220.202848600486000
2021-05-31Exemplar Performance Series F0.12060.63742640500
2021-04-30Fidelity® NASDAQ Composite Index®0.06070.001113288422046.5373
2021-05-31Arrow Canadian Advantage Alt Cl F0.05880.12951286200
2020-12-31Picton Mahoney Fortified Arbtrg Alt Fd F0.03290.11517200-47400-86.8132
2021-03-31Vivaldi Multi-Strategy I0.03240.196708400
2020-12-31Picton Mahoney Arbitrage Fund F0.02240.1174900-300-5.7692
2021-03-31Relative Value CIA0.01820.0318397500
Total 0.90661.886198442+5120+2.6%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Greenrose Acquisition Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.025-2.198+9%0.426-575%0.063-3303%0.063-3303%
Book Value Growth--0.2890.601-52%0.995-71%635.400-100%635.400-100%
Book Value Per Share--0.8222.748-70%9.112-91%5.478-85%5.478-85%
Book Value Per Share Growth--0.2890.601-52%1.055-73%513.403-100%513.403-100%
Current Ratio--0.1020.154-34%0.737-86%1.260-92%1.260-92%
Debt To Asset Ratio--0.9170.781+17%0.027+3278%0.391+135%0.391+135%
Debt To Equity Ratio--11.0944.883+127%0.747+1386%4.347+155%4.347+155%
Dividend Per Share----0%-0%-0%-0%
Eps---2.0380.357-670%-0.073-96%0.085-2497%0.085-2497%
Eps Growth---1.48628.122-105%-0.703-53%11.080-113%11.080-113%
Free Cash Flow Per Share---0.270-0.788+191%-0.034-87%-0.256-5%-0.256-5%
Free Cash Flow Per Share Growth---2.977-28.427+855%0.681-537%-10.848+264%-10.848+264%
Free Cash Flow To Equity Per Share---0.121-9.565+7792%0.007-1821%-2.332+1824%-2.332+1824%
Free Cash Flow To Equity Per Share Growth---0.620-437.865+70546%1.232-150%323.094-100%323.094-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--39.735--------
Intrinsic Value_10Y_min---8.686--------
Intrinsic Value_1Y_max---0.372--------
Intrinsic Value_1Y_min---2.782--------
Intrinsic Value_3Y_max--2.201--------
Intrinsic Value_3Y_min---6.754--------
Intrinsic Value_5Y_max--8.773--------
Intrinsic Value_5Y_min---8.933--------
Net Profit Margin---4.591-1.874-59%--100%-0.577-87%-0.577-87%
Operating Margin---0.618-0.367-41%--100%-0.113-82%-0.113-82%
Operating Ratio--2.4331.811+34%-+100%0.557+337%0.557+337%
Pb Ratio0.584-138%1.3871.066+30%1.111+25%0.860+61%0.860+61%
Pe Ratio-0.236+58%-0.559-2.253+303%-166.028+29578%-190.842+34014%-190.842+34014%
Peg Ratio--0.3766.372-94%-187.061+49800%-694.082+184511%-694.082+184511%
Price Per Share0.480-138%1.1402.718-58%10.040-89%5.432-79%5.432-79%
Price To Total Gains Ratio-0.237+58%-0.563-3.411+506%-28.103+4892%-193.389+34255%-193.389+34255%
Profit Growth---1.48628.122-105%0.664-324%34.604-104%34.604-104%
Quick Ratio--0.0130.022-40%0.643-98%0.221-94%0.221-94%
Return On Assets---0.2050.011-2038%-0.005-98%0.001-26882%0.001-26882%
Return On Equity---2.480-0.419-83%-0.135-95%-0.183-93%-0.183-93%
Revenue Growth--0.8540.988-14%--0.988-14%0.988-14%
Total Gains Per Share---2.025-2.198+9%0.426-575%0.063-3303%0.063-3303%
Total Gains Per Share Growth---1.551-11.531+644%2.718-157%20615.569-100%20615.569-100%
Usd Book Value--14533000.00048598000.000-70%169308374.000-91%107083932.000-86%107083932.000-86%
Usd Book Value Change Per Share---2.025-2.198+9%0.426-575%0.063-3303%0.063-3303%
Usd Book Value Per Share--0.8222.748-70%9.112-91%5.478-85%5.478-85%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---2.0380.357-670%-0.073-96%0.085-2497%0.085-2497%
Usd Free Cash Flow---4781000.000-1814000.000-62%-623272.500-87%-808037.923-83%-808037.923-83%
Usd Free Cash Flow Per Share---0.270-0.788+191%-0.034-87%-0.256-5%-0.256-5%
Usd Free Cash Flow To Equity Per Share---0.121-9.565+7792%0.007-1821%-2.332+1824%-2.332+1824%
Usd Price Per Share0.480-138%1.1402.718-58%10.040-89%5.432-79%5.432-79%
Usd Profit---36035000.0006319018.000-670%-871109.000-98%1686093.000-2237%1686093.000-2237%
Usd Revenue--7849000.0006307250.000+24%-+100%1940692.308+304%1940692.308+304%
Usd Total Gains Per Share---2.025-2.198+9%0.426-575%0.063-3303%0.063-3303%
 EOD+3 -2MRQTTM+15 -24YOY+3 -355Y+6 -3310Y+6 -33

4.2. Fundamental Score

Let's check the fundamental score of Greenrose Acquisition Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.236
Price to Book Ratio (EOD)Between0-10.584
Net Profit Margin (MRQ)Greater than0-4.591
Operating Margin (MRQ)Greater than0-0.618
Quick Ratio (MRQ)Greater than10.013
Current Ratio (MRQ)Greater than10.102
Debt to Asset Ratio (MRQ)Less than10.917
Debt to Equity Ratio (MRQ)Less than111.094
Return on Equity (MRQ)Greater than0.15-2.480
Return on Assets (MRQ)Greater than0.05-0.205
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Greenrose Acquisition Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.761
Ma 20Greater thanMa 500.693
Ma 50Greater thanMa 1000.547
Ma 100Greater thanMa 2000.855
OpenGreater thanClose0.480
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets175,766
Total Liabilities161,233
Total Stockholder Equity14,533
 As reported
Total Liabilities 161,233
Total Stockholder Equity+ 14,533
Total Assets = 175,766

Assets

Total Assets175,766
Total Current Assets15,425
Long-term Assets15,425
Total Current Assets
Cash And Cash Equivalents 962
Net Receivables 1,954
Inventory 11,878
Other Current Assets 33
Total Current Assets  (as reported)15,425
Total Current Assets  (calculated)14,827
+/- 598
Long-term Assets
Property Plant Equipment 24,671
Goodwill 32,637
Intangible Assets 101,834
Other Assets 1,199
Long-term Assets  (as reported)160,341
Long-term Assets  (calculated)160,341
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities151,063
Long-term Liabilities10,170
Total Stockholder Equity14,533
Total Current Liabilities
Short Long Term Debt 132,317
Accounts payable 4,617
Other Current Liabilities 3,271
Total Current Liabilities  (as reported)151,063
Total Current Liabilities  (calculated)140,205
+/- 10,858
Long-term Liabilities
Long term Debt 9,573
Other Liabilities 597
Long-term Liabilities Other 56
Deferred Long Term Liability 1,000
Long-term Liabilities  (as reported)10,170
Long-term Liabilities  (calculated)11,226
+/- 1,056
Total Stockholder Equity
Common Stock2
Total Stockholder Equity (as reported)14,533
Total Stockholder Equity (calculated)2
+/- 14,531
Other
Capital Stock2
Common Stock Shares Outstanding 17,683
Net Debt 140,928
Net Invested Capital 156,423
Net Tangible Assets -119,938
Net Working Capital -135,638



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
167
658
174,992
174,764
174,457
174,012
174,337
173,778
174,012
239,093
222,424
216,360
175,766
175,766216,360222,424239,093174,012173,778174,337174,012174,457174,764174,992658167
   > Total Current Assets 
25
54
1,387
1,116
804
355
864
325
355
27,492
20,398
18,371
15,425
15,42518,37120,39827,4923553258643558041,1161,3875425
       Cash And Cash Equivalents 
25
0
1,315
1,065
769
310
772
253
310
7,240
1,864
981
962
9629811,8647,2403102537723107691,0651,315025
       Short-term Investments 
0
0
0
0
0
0
0
0
0
1,694
1,475
633
0
06331,4751,694000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
1,197
1,866
2,604
1,954
1,9542,6041,8661,197000000000
       Inventory 
0
0
0
0
0
0
0
0
0
12,513
11,732
11,121
11,878
11,87811,12111,73212,513000000000
   > Long-term Assets 
142
0
173,605
173,648
173,652
173,657
173,473
173,453
173,657
211,601
202,026
197,989
160,341
160,341197,989202,026211,601173,657173,453173,473173,657173,652173,648173,6050142
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
25,209
25,053
25,215
24,671
24,67125,21525,05325,209000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
71,658
66,038
65,791
32,637
32,63765,79166,03871,658000000000
       Long Term Investments 
0
0
0
0
0
173,657
173,473
173,403
173,657
0
0
0
0
0000173,657173,403173,473173,65700000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
113,684
109,734
105,784
101,834
101,834105,784109,734113,684000000000
       Other Assets 
142
604
173,605
173,648
173,652
173,657
173,473
50
174,558
1,050
1,201
1,199
1,199
1,1991,1991,2011,050174,55850173,473173,657173,652173,648173,605604142
> Total Liabilities 
143
635
1,284
1,237
1,272
3,974
5,084
5,873
3,974
170,010
161,993
166,015
161,233
161,233166,015161,993170,0103,9745,8735,0843,9741,2721,2371,284635143
   > Total Current Liabilities 
143
635
284
237
272
400
898
1,532
400
130,926
128,935
124,563
151,063
151,063124,563128,935130,9264001,532898400272237284635143
       Short-term Debt 
0
631
0
0
0
0
0
0
0
0
0
0
0
000000000006310
       Short Long Term Debt 
0
0
0
0
0
0
0
300
1,095
108,656
107,205
110,083
132,317
132,317110,083107,205108,6561,0953000000000
       Accounts payable 
0
0
86
98
0
400
898
1,532
400
1,530
2,641
3,447
4,617
4,6173,4472,6411,5304001,5328984000988600
       Other Current Liabilities 
0
0
188
140
36
0
0
0
0
3,393
3,220
3,018
3,271
3,2713,0183,2203,39300003614018800
   > Long-term Liabilities 
0
0
1,000
1,000
1,000
3,574
4,187
4,341
3,574
39,084
33,058
41,452
10,170
10,17041,45233,05839,0843,5744,3414,1873,5741,0001,0001,00000
       Long term Debt Total 
0
0
0
0
0
3,574
4,187
4,341
3,574
0
0
0
0
00003,5744,3414,1873,57400000
       Warrants
0
0
0
0
0
0
0
162,905
0
0
0
0
0
00000162,9050000000
       Other Liabilities 
0
0
168,708
168,526
168,185
167,612
165,916
165,795
175,626
39,084
33,058
31,729
597
59731,72933,05839,084175,626165,795165,916167,612168,185168,526168,70800
> Total Stockholder Equity
23
23
173,708
173,526
173,185
5,000
5,000
5,000
-3,401
69,083
60,431
50,345
14,533
14,53350,34560,43169,083-3,4015,0005,0005,000173,185173,526173,7082323
   Common Stock
0
0
1
1
1
1
1
1
0
2
2
2
2
2222011111100
   Retained Earnings 
-2
-2
653
471
129
-1,612
-2,397
-3,745
-3,402
-1,778
-16,346
-26,682
-62,717
-62,717-26,682-16,346-1,778-3,402-3,745-2,397-1,612129471653-2-2
   Capital Surplus 
25
25
0
0
0
6,611
7,396
8,745
0
0
0
0
0
000008,7457,3966,6110002525
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
0
0
0
167,612
0
0
0
0
0
0
0
0000000167,61200000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = -19,536
456
0
Interest Expense0
Earnings Before Interest and Taxes (ebit)-19,5360
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares83,304
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications